Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

BACKGROUND: Patients with ischemic stroke or transient ischemic attack (TIA) are at increased risk for future cardiovascular events despite current preventive therapies. The identification of insulin resistance as a risk factor for stroke and myocardial infarction raised the possibility that pioglit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Kernan, W.N., Viscoli, C.M., Furie, K.L., Young, L.H., Inzucchi, S.E., Gorman, M., Guarino, P.D., Lovejoy, A.M., Peduzzi, P.N., Conwit, R., Brass, L.M., Schwartz, G.G., Adams, H.P., Berger, L., Carolei, A., Clark, W., Coull, B., Ford, G.A., Kleindorfer, D., O’Leary, J.R., Parsons, M.W., Ringleb, P., Sen, S., Spence, J.D., Tanne, D., Wang, D., Winder, T.R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887756/
https://ncbi.nlm.nih.gov/pubmed/26886418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1506930
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars